Optoacoustic mesoscopy for biomedicine

M Omar, J Aguirre, V Ntziachristos - Nature biomedical engineering, 2019 - nature.com
Fuelled by innovation, optical microscopy plays a critical role in the life sciences and
medicine, from basic discovery to clinical diagnostics. However, optical microscopy is limited …

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I

M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky… - Circulation, 2003 - Am Heart Assoc
Atherosclerotic cardiovascular disease results in> 19 million deaths annually, and coronary
heart disease accounts for the majority of this toll. Despite major advances in treatment of …

Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery …

M Goeller, S Achenbach, S Cadet, AC Kwan… - JAMA …, 2018 - jamanetwork.com
Importance Pericoronary adipose tissue (PCAT) computed tomography (CT) attenuation
measured from coronary CT angiography (CTA) may be a promising metric in identifying …

Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery …

H Samady, P Eshtehardi, MC McDaniel, J Suo… - Circulation, 2011 - Am Heart Assoc
Background Experimental studies suggest that low wall shear stress (WSS) promotes
plaque development and high WSS is associated with plaque destabilization. We …

Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image …

F Prati, E Regar, GS Mintz, E Arbustini… - European heart …, 2010 - academic.oup.com
Optical coherence tomography (OCT) is a novel intravascular imaging modality, based on
infrared light emission, that enables a high resolution arterial wall imaging, in the range of …

Passive and active drug targeting: drug delivery to tumors as an example

VP Torchilin - Drug delivery, 2010 - Springer
The paradigm of using nanoparticulate pharmaceutical carriers has been well established
over the past decade, both in pharmaceutical research and in the clinical setting. Drug …

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective …

M Haude, R Erbel, P Erne, S Verheye, H Degen… - The Lancet, 2013 - thelancet.com
Background Bioabsorbable vascular scaffolds were developed to overcome limitations of
permanent bare-metal or drug-eluting coronary stents—ie, stent thrombosis (despite …

In-stent neoatherosclerosis: a final common pathway of late stent failure

SJ Park, SJ Kang, R Virmani, M Nakano… - Journal of the American …, 2012 - jacc.org
Percutaneous coronary intervention with stenting is the most widely performed procedure for
the treatment of symptomatic coronary disease, and drug-eluting stents (DES) have …

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

PW Serruys, JA Ormiston, Y Onuma, E Regar… - The Lancet, 2009 - thelancet.com
Background Drug-eluting metallic coronary stents predispose to late stent thrombosis,
prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair …

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

JA Ormiston, PW Serruys, E Regar, D Dudek… - The Lancet, 2008 - thelancet.com
Background A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall
when needed and then disappears once the acute recoil and constrictive remodelling …